Jacobs IJ - Search Results

1

MSI-low, a real phenomenon which varies in frequency among cancer types.

Halford SE, Sawyer EJ, Lambros MB, Gorman P, Macdonald ND, Talbot IC, Foulkes WD, Gillett CE, Barnes DM, Akslen LA, Lee K, Jacobs IJ, Hanby AM, Ganesan TS, Salvesen HB, Bodmer WF, Tomlinson IP, Roylance RR. Halford SE, et al. Among authors: jacobs ij. J Pathol. 2003 Nov;201(3):389-94. doi: 10.1002/path.1453. J Pathol. 2003. PMID: 14595750

2

Screening for ovarian cancer.

MacDonald ND, Rosenthal AN, Jacobs IJ. MacDonald ND, et al. Among authors: jacobs ij. Ann Acad Med Singap. 1998 Sep;27(5):676-82. Ann Acad Med Singap. 1998. PMID: 9919339 Review.

3

Is there a place for screening in ovarian cancer?

MacDonald ND, Jacobs IJ. MacDonald ND, et al. Among authors: jacobs ij. Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):155-7. doi: 10.1016/s0301-2115(98)00219-x. Eur J Obstet Gynecol Reprod Biol. 1999. PMID: 10206408 Review. No abstract available.

4

Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.

Menon U, Talaat A, Jeyarajah AR, Rosenthal AN, MacDonald ND, Skates SJ, Sibley K, Oram DH, Jacobs IJ. Menon U, et al. Among authors: jacobs ij. Br J Cancer. 1999 Jul;80(10):1644-7. doi: 10.1038/sj.bjc.6690575. Br J Cancer. 1999. PMID: 10408412 Free PMC article.

5

Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.

Zweemer RP, Shaw PA, Verheijen RM, Ryan A, Berchuck A, Ponder BA, Risch H, McLaughlin JR, Narod SA, Menko FH, Kenemans P, Jacobs IJ. Zweemer RP, et al. Among authors: jacobs ij. J Clin Pathol. 1999 May;52(5):372-5. doi: 10.1136/jcp.52.5.372. J Clin Pathol. 1999. PMID: 10560359 Free PMC article.

6

Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.

Menon U, Talaat A, Rosenthal AN, Macdonald ND, Jeyerajah AR, Skates SJ, Sibley K, Oram DH, Jacobs IJ. Menon U, et al. Among authors: jacobs ij. BJOG. 2000 Feb;107(2):165-9. doi: 10.1111/j.1471-0528.2000.tb11685.x. BJOG. 2000. PMID: 10688498

7

Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas.

MacDonald ND, Salvesen HB, Ryan A, Iversen OE, Akslen LA, Jacobs IJ. MacDonald ND, et al. Among authors: jacobs ij. Cancer Res. 2000 Mar 15;60(6):1750-2. Cancer Res. 2000. PMID: 10749149

8

Methylation of hMLH1 in a population-based series of endometrial carcinomas.

Salvesen HB, MacDonald N, Ryan A, Iversen OE, Jacobs IJ, Akslen LA, Das S. Salvesen HB, et al. Among authors: jacobs ij. Clin Cancer Res. 2000 Sep;6(9):3607-13. Clin Cancer Res. 2000. PMID: 10999752

9

PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma.

Salvesen HB, MacDonald N, Ryan A, Jacobs IJ, Lynch ED, Akslen LA, Das S. Salvesen HB, et al. Among authors: jacobs ij. Int J Cancer. 2001 Jan 1;91(1):22-6. doi: 10.1002/1097-0215(20010101)91:1<22::aid-ijc1002>3.0.co;2-s. Int J Cancer. 2001. PMID: 11149415 Free article.

10

Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.

Stefansson I, Akslen LA, MacDonald N, Ryan A, Das S, Jacobs IJ, Salvesen HB. Stefansson I, et al. Among authors: jacobs ij. Clin Cancer Res. 2002 Jan;8(1):138-43. Clin Cancer Res. 2002. PMID: 11801550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

263 results

Search Page